News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

681,550 Results

Type

Article (39504)
Company Profile (253)
Press Release (641793)

Section

Business (204279)
Career Advice (1994)
Deals (35396)
Drug Delivery (79)
Drug Development (80743)
Employer Resources (167)
FDA (16043)
Job Trends (14842)
News (344715)
Policy (32505)

Tag

Date

Last 7 days (657)
Last 30 days (2050)
Last 365 days (37161)
2024 (25702)
2023 (40138)
2022 (51244)
2021 (55813)
2020 (54211)
2019 (46690)
2018 (35178)
2017 (32281)
2016 (31673)
2015 (37787)
2014 (31481)
2013 (26558)
2012 (28755)
2011 (29438)
2010 (27552)

Filters

Type

Article (39504)
Company Profile (253)
Press Release (641793)

Section

Business (204279)
Career Advice (1994)
Deals (35396)
Drug Delivery (79)
Drug Development (80743)
Employer Resources (167)
FDA (16043)
Job Trends (14842)
News (344715)
Policy (32505)

Tag

Date

Last 7 days (657)
Last 30 days (2050)
Last 365 days (37161)
2024 (25702)
2023 (40138)
2022 (51244)
2021 (55813)
2020 (54211)
2019 (46690)
2018 (35178)
2017 (32281)
2016 (31673)
2015 (37787)
2014 (31481)
2013 (26558)
2012 (28755)
2011 (29438)
2010 (27552)

681,550 Results for "clearside biomedical inc".

Sort By

BioMidwest

Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting

Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.

June 12, 2024
·
7 min read
BioMidwest

Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced plans to host a virtual key opinion leader event on Wednesday, July 24, 2024 from 8:00 - 9:15 am ET.

June 27, 2024
·
6 min read
Business

Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

May 9, 2024
·
8 min read
Business

Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors

Clearside Biomedical, Inc. announced that Anthony S. Gibney has been appointed to the Company’s Board of Directors, effective April 15, 2024.

April 16, 2024
·
5 min read
BioMidwest

Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®

Clearside Biomedical, Inc. announced that RETINA®, The Journal of Retinal and Vitreous Diseases, has published new guidelines that represent best practices for injection into the suprachoroidal space.

May 21, 2024
·
6 min read
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference

Clearside Biomedical, Inc. (Nasdaq: CLSD) announced today that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 9:30 a.m. ET in New York, NY.

May 8, 2024
·
1 min read
Business

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced that its first quarter 2024 financial results will be reported on Thursday, May 9, 2024 after the close of the financial markets.

April 30, 2024
·
1 min read
Business

Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced that Victor Chong, M.D., MBA was appointed Chief Medical Officer on March 14, 2024.

March 18, 2024
·
6 min read
BioMidwest

Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Clearside Biomedical, Inc. announced that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer, and Victor Chong, M.D., MBA, Chief Medical Officer, will participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 3:00 p.m. ET.

April 2, 2024
·
1 min read
Business

Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

August 12, 2024
·
11 min read

1 of 68,155

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin